Circulating microRNA expression is reduced in chronic kidney disease

Nephrology Dialysis Transplantation

Volumn 26, Issue 11, 2011, Pages 3794-3802

  Neal, Calida S ^a   Michael, Michael Z ^a   Pimlott, Letitia K ^a   Yong, Tuck Y ^a   Li, Jordan Y Z ^a   Gleadle, Jonathan M ^a  

^a FLINDERS UNIVERSITY   (Australia)

Author keywords

biomarker; chronic kidney disease; exosomes; microRNA; renal failure

Indexed keywords

CREATININE; MICRORNA; MICRORNA 155; MICRORNA 16; MICRORNA 21; MICRORNA 210; MICRORNA 638; UNCLASSIFIED DRUG;

ADULT; AGED; ANEMIA; ARTICLE; CHRONIC KIDNEY FAILURE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DISEASE SEVERITY; FEMALE; GLOMERULUS FILTRATION RATE; HEMODIALYSIS; HUMAN; HYPERPARATHYROIDISM; KIDNEY DYSFUNCTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; UREMIA;

ADULT; AGED; AGED, 80 AND OVER; ANEMIA; BIOLOGICAL MARKERS; EXOSOMES; FEMALE; FOLLOW-UP STUDIES; GLOMERULAR FILTRATION RATE; HUMANS; HYPERPARATHYROIDISM; KIDNEY FAILURE, CHRONIC; KIDNEY FUNCTION TESTS; MALE; MICRORNAS; MIDDLE AGED; NEOPLASTIC CELLS, CIRCULATING; PROGNOSIS; REAL-TIME POLYMERASE CHAIN REACTION; RENAL DIALYSIS; UREMIA;

EID: 80155210177     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfr485     Document Type: Article

References (59)

1. Bartel DP. MicroRNAs: Target recognition and regulatory functions. Cell 2009; 136: 215-233
2. Chiang HR, Schoenfeld LW, Ruby JG et al. Mammalian microRNAs: Experimental evaluation of novel and previously annotated genes. Genes Dev 2010; 24: 992-1009
3. Lu J, Getz G, Miska EA et al. MicroRNA expression profiles classify human cancers. Nature 2005; 435: 834-838
4. Volinia S, Calin G, Liu C et al. A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci U S A 2006; 103: 2257-2261
5. Ikeda S, Pu WT. Expression and function of MicroRNAs in heart disease. Curr Drug Targets 2010; 11: 1-13
6. Kato M, Arce L, Natarajan R. MicroRNAs and their role in progressive kidney diseases. Clin J Am Soc Nephrol 2009; 4: 1255-1266
7. Li JY, Yong TY, Michael MZ et al. Review: The role of microRNAs in kidney disease. Nephrology 2010; 15: 599-608
8. Sun H, Li QW, Lv XY et al. MicroRNA-17 post-transcriptionally regulates polycystic kidney disease-2 gene and promotes cell proliferation. Mol Biol Rep 2010; 37: 2951-2958
9. Pandey P, Brors B, Srivastava PK et al. Microarray-based approach identifies microRNAs and their target functional patterns in polycystic kidney disease. BMC Genomics 2008; 9: 624
10. Neal CS, Michael MZ, Rawlings LH et al. The VHL-dependent regulation of microRNAs in renal cancer. BMC Med 2010; 8: 64
11. Jung M, Mollenkopf HJ, Grimm C et al. MicroRNA profiling of clear cell renal cell cancer identifies a robust signature to define renal malignancy. J Cell Mol Med 2009; 13: 3918-3928
12. Nakada C, Matsuura K, Tsukamoto T et al. Genome-wide microRNA expression profiling in renal cell carcinoma: Significant down regulation of miR-141 and miR-200c. J Pathol 2008; 216: 418-427
13. Chow T-fF, Youssef YM, Lianidou E et al. Differential expression profiling of microRNAs and their potential involvement in renal cell carcinoma pathogenesis. Clin Biochem 2010; 43: 150-158
14. Anglicheau D, Sharma V, Ding R et al. MicroRNA expression profiles predictive of human renal allograft status. Proc Natl Acad Sci U S A 2009; 106: 5330-5335
15. Harvey SJ, Jarad G, Cunningham J et al. Podocyte-specific deletion of dicer alters cytoskeletal dynamics and causes glomerular disease. J Am Soc Nephrol 2008; 19: 2150-2158
16. Ho J, Ng KH, Rosen S et al. Podocyte-specific loss of functional microRNAs leads to rapid glomerular and tubular injury. J Am Soc Nephrol 2008; 19: 2069-2075
17. Shi S, Yu L, Chiu C et al. Podocyte-selective deletion of dicer induces proteinuria and glomerulosclerosis. J Am Soc Nephrol 2008; 19: 2159-2169
18. Wei Q, Bhatt K, He HZ et al. Targeted deletion of Dicer from proximal tubules protects against renal ischemia-reperfusion injury. J Am Soc Nephrol 2010; 21: 756-761
19. Cortez M, Calin G. MicroRNA identification in plasma and serum: A new tool to diagnose and monitor diseases. Expert Opin Biol Ther 2009; 9: 703-711
20. Mitchell PS, Parkin RK, Kroh EM et al. Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci U S A 2008; 105: 10513-10518
21. Park N, Zhou H, Elashoff D et al. Salivary microRNA: Discovery, characterization, and clinical utility for oral cancer detection. Clin Cancer Res 2009; 15: 5473-5477
22. Hanke M, Hoefig K, Merz H et al. A robust methodology to study urine microRNA as tumor marker: MicroRNA-126 and microRNA- 182 are related to urinary bladder cancer. Urol Oncol 2010; 28: 655-661
23. Weber JA, Baxter DH, Zhang S et al. The microRNA spectrum in 12 body fluids. Clin Chem 2010; 56: 1733-1741
24. Chen X, Ba Y, Ma L et al. Characterization of microRNAs in serum: A novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res 2008; 18: 997-1006
25. Chin LJ, Slack FJ. A truth serum for cancer-microRNAs have major potential as cancer biomarkers. Cell Res 2008; 18: 983-984
26. Gilad S, Meiri E, Yogev Y et al. Serum microRNAs are promising novel biomarkers. PLoS One 2008; 3: E3148
27. Wang GK, Zhu JQ, Zhang JT et al. Circulating microRNA: A novel potential biomarker for early diagnosis of acute myocardial infarction in humans. Eur Heart J 2010; 31: 659-666
28. Valadi H, Ekstrom K, Bossios A et al. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nature Cell Biol 2007; 9: 654-659
29. Ratajczak J, Wysoczynski M, Hayek F et al. Membrane-derived microvesicles (MV): Important and underappreciated mediators of cellto- cell communication. Leukemia 2006; 20: 1487-1495
30. Caby M, Lankar D, Vincendeau-Scherrer C et al. Exosomal-like vesicles are present in human blood plasma. Int Immunol 2005; 17: 879-887
31. Pisitkun T, Shen RF, Knepper MA. Identification and proteomic profiling of exosomes in human urine. Proc Natl Acad Sci U S A 2004; 101: 13368-13373
32. Michael A, Bajracharya S, Yuen P et al. Exosomes from human saliva as a source of microRNA biomarkers. Oral Dis 2010; 16: 34-38
33. Koga K, Matsumoto K, Akiyosi T et al. Purification, characterization and biological significance of tumor-derived exosomes. Anticancer Res 2005; 25: 3703-3708
34. Rabinowits G, Gercel-Taylor C, Day J et al. Exosomal microRNA: A diagnostic marker for lung cancer. Clin Lung Cancer 2009; 10: 42-46
35. Rosell R, Wei J, Taron M. Circulating microRNA signatures of tumor-derived exosomes for early diagnosis of non-small-cell lung cancer. Clin Lung Cancer 2009; 10: 8-9
36. Taylor DD, Gercel-Taylor C. MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer. Gynecol Oncol 2008; 110: 13-21
37. Zhou H, Cheruvanky A, Hu X et al. Urinary exosomal transcription factors, a new class of biomarkers for renal disease. Kidney Int 2008; 74: 613-621
38. Gonzales P, Pisitkun T, Knepper MA. Urinary exosomes: Is there a future? Nephrol Dial Transplant 2008; 23: 1799-1801
39. Miranda KC, Bond DT, McKee M et al. Nucleic acids within urinary exosomes/microvesicles are potential biomarkers for renal disease. Kidney Int 2010; 78: 191-199
40. Rood IM, Deegens JK, Merchant ML et al. Comparison of three methods for isolation of urinary microvesicles to identify biomarkers of nephrotic syndrome. Kidney Int 2010; 78: 810-816
41. Liu N, Ding H, Vanderheydena JL et al. Radiolabeling small RNA with technetium-99m for visualizing cellular delivery and mouse biodistribution. Nucl Med Biol 2007; 34: 399-404
42. Rifai A, Brysch W, Fadden K et al. Clearance kinetics, biodistribution, and organ saturability of phosphorothioate oligodeoxynucleotides in mice. Am J Pathol 1996; 149: 717-726
43. Sepp-Lorenzino L, Ruddy M. Challenges and opportunities for local and systemic delivery of siRNA and antisense oligonucleotides. Clin Pharmacol Ther 2008; 84: 628-632
44. Amabile N, Guerin AP, Leroyer A et al. Circulating endothelial microparticles are associated with vascular dysfunction in patients with end-stage renal failure. J Am Soc Nephrol 2005; 16: 3381-3388
45. Faure V, Dou L, Sabatier F et al. Elevation of circulating endothelial microparticles in patients with chronic renal failure. J Thromb Haemost 2006; 4: 566-573
46. Levey AS, Bosch JP, Lewis JB et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation. Ann Int Med 1999; 130: 461-470
47. Thery C, Amigorena S, Raposo G et al. Isolation and characterization of exosomes from cell culture supernatants and biological fluids. Curr Protoc Cell Biol 2006; Chapter 3:Unit 3 22
48. Escola JM, Kleijmeer MJ, StoorvogelWet al. Selective enrichment of tetraspan proteins on the internal vesicles of multivesicular endosomes and on exosomes secreted by human B-lymphocytes. J Biol Chem 1998; 273: 20121-20127
49. Lawrie CH, Gal S, Dunlop HM et al. Detection of elevated levels of tumour-associated microRNAs in serum of patients with diffuse large B-cell lymphoma. Br J Haemat 2008; 141: 672-675
50. Wang J, Chen J, Chang P et al. MicroRNAs in plasma of pancreatic ductal adenocarcinoma patients as novel blood-based biomarkers of disease. Cancer Prev Res (Phila) 2009; 2: 807-813
51. Tanaka M, Oikawa K, TakanashiMet al. Down-regulation of miR-92 in human plasma is a novel marker for acute leukemia patients. PLoS One 2009; 4: E5532
52. Weickmann JL, Olson EM, Glitz DG. Immunologieal assay of pancreatic ribonuclease in serum as an indicator of pancreatic cancer. Cancer Res 1984; 44: 1682-1687
53. Karpetsky T, Humphrey R, Levy C. Influence of renal insufficiency on levels of serum ribonuclease in patients with multiple myeloma. J Natl Cancer Inst 1977; 58: 875-880
54. Humphrey RL, Karpetsky TP, Neuwelt EA et al. Levels of serum ribonuclease as an Indicator of renal insufficiency in patients with leukemia. Cancer Res 1977; 37: 2015-2022
55. Connolly J, Herriott R, Gupta S. Ribonuclease in normal and uremie human blood. Br J Exp Pathol 1966; 43: 402-408
56. Rabinovitch M, Liverman B, Fausto N. Plasma ribonuclease activity in human uremia. J Lab Clin Med 1959; 187: 525-528
57. Rabinovitch M, Dohi S. Increase in serum ribonuclease activity after bilateral nephrectomy. Am J Physiol 1956; 187: 525-528
58. Arroyo JD, Chevillet JR, Kroh EM et al. Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma. Proc Natl Acad Sci U S A 2011; 108: 5003-5008
59. Vickers KC, Palmisano BT, Shoucri BM et al. MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins. Nat Cell Biol 2011; 13: 423-433